April 22, 2021 Comments Off on New patent for Intra-cellular drug CAPLYTA Posted in: Patent Added Annual Drug Patent Expirations for CAPLYTA Caplyta is a drug marketed by Intra-cellular and is included in one NDA. There are ten patents protecting this drug. CAPLYTA drug price trends.…
The post New patent for Intra-cellular drug CAPLYTA appeared fir…
April 22, 2021 Comments Off on New patent for Beigene drug BRUKINSA Posted in: Patent Added Annual Drug Patent Expirations for BRUKINSA Brukinsa is a drug marketed by Beigene and is included in one NDA. There is one patent protecting this drug. This drug has twenty-three…
The post New patent for Beigene drug BRUKINSA appeared first on DrugPat…
